Plasma levels in sepsis patients of annexin A1, lipoxin A4, macrophage inflammatory protein-3a, and neutrophil gelatinase-associated lipocalin

Journal of the Chinese Medical Association

Volumn 76, Issue 9, 2013, Pages 486-490

  Tsai, Wen Hui ^a   Shih, Chung Hung ^a   Yu, Yuan Bin ^b,c   Hsu, Hui Chi ^b,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Annexin A1; Lipoxin A4; Macrophage inflammatory protein 3a; Neutrophil gelatinase associated lipocalin; Sepsis

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; LIPOCORTIN 1; LIPOXIN A; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; STEROID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEPSIS; STEROID THERAPY; SURVIVOR; TREATMENT OUTCOME; VENTILATOR;

ANNEXIN A1; LIPOXIN A4; MACROPHAGE INFLAMMATORY PROTEIN-3A; NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN; SEPSIS;

ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; ANNEXIN A1; CHEMOKINE CCL20; FEMALE; HUMANS; LIPOCALINS; LIPOXINS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; SEPSIS;

EID: 84883284171     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2013.05.004     Document Type: Article

References (42)

1. Newton S., Ding Y., Chung C.S., Chen Y., Lomas-Neira J.L., Ayala A. Sepsis-induced changes in macrophage co-stimulatory molecule expression:CD86 as a regulator of anti-inflammatory IL-10 response. Surg Infect (Larchmt) 2004, 5:375-383.
2. Osuchowski M.F., Welch K., Siddiqui J., Remick D.G. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006, 177:1967-1974.
3. Boomer J.S., To K., Chang K.C., Takasu O., Osborne D.F., Walton A.H., et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011, 306:2594-2605.
4. Novotny A.R., Reim D., Assfalg V., Altmayr F., Friess H.M., Emmanuel K., et al. Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis. Immunobiology 2012, 217:616-621.
5. Tamayo E., Fernandez A., Almansa R., Carrasco E., Heredia M., Lajo C., et al. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur Cytokine Netw 2011, 22:82-87.
6. Parrillo J.E., Parker M.M., Natanson C., Suffredini A.F., Danner R.L., Cunnion E.R., et al. Septic shock in humans, advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Intern Med 1990, 113:227-240.
7. Pinsky M.R., Vincent J.L., Deviere J., Alegre M., Kahn R.J., Dupont E. Serum cytokine levels in human septic shock: relation to multiple-system organ dysfunction and mortality. Chest 1993, 103:565-575.
8. Marchant A., Deviere J., Byl B., De Groote D., Vincent J., Goldman M. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 1995, 172:296-301.
9. Friedman G., Jankowski S., Marchant A., Goldman M., Kahn R.J., Vincent J.L. Blood interleukin-10 levels parallel the severity of septic shock. J Crit Care 1997, 12:183-187.
10. Van Zee K.J., Kohno T., Fischer E., Rock C.S., Moldawer L.L., Lowry S.F. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha invitro and invivo. Proc Natl Acad Sci U S A 1992, 89:4845-4849.
11. Pruitt J.H., Edwards P.D., Harward T.R., Seeger J.W., Martin T.D., Smith C., et al. Soluble interleukin-1 type-II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 1996, 87:3282-3288.
12. de Pablo R., Monserrat J., Reyes E., Diaz-Martin D., Zapata M.R., Carballo F., et al. Mortality in patients with septic shock correlates with anti-inflammatory but not proinflammatory immunomodulatory molecules. J Intensive Care Med 2011, 26:125-132.
13. Waage A., Halstensen A., Espevick T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987, 1:355-357.
14. Girardin E., Grau C.E., Dayer J.M., Roux-Lombard P., Lambert P.H. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988, 319:397-400. J5 Study Group.
15. Damas P., Ledoux D., Nys M., Vrindts Y., De Groote D., Franchimont P., et al. Cytokine serum level during severe sepsis: human IL-6 as a marker of severity. Ann Surg 1992, 215:356-362.
16. Lehmann A.K., Halstensen A., Sornes S., Rokke O., Waage A. High levels of interleukin-10 in serum are associated with fatality in meningococcal disease. Infect Immun 1995, 63:2109-2112.
17. Hazelcet J.A., Kornelisse R.F., van der Pouw Kraan T.C., Joosten K.F., van der Voort E., van Mierlo G., et al. Interleukin-12 levels during the initial phase of septic shock with purpura in children:relation to severity of disease. Cytokine 1997, 9:711-716.
18. Kasai T., Inada K., Takakuwa T., Yamada H., Inoue Y., Shimamura T., et al. Anti-inflammatory cytokine levels in patients with septic shock. Res Commun Mol Pathol Pharmacol 1997, 98:34-42.
19. Van der Poll T., de Waal Malefyt R., Coyle S.M., Lowry S.F. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10 and IL-13. J Infect Dis 1997, 175:118-122.
20. Gogos C.A., Drosou E., Bassaris H.P., Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000, 181:176-180.
21. Schmidt-Ott K.M., Mori K., Li J.Y., Kalandadze A., Cohen D.J., Devarajan P., et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007, 18:407-413.
22. Hieshima K., Imai T., Opdenakker G., Van Damme J., Kusuda J., Tei H., et al. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem 1997, 272:5846-5853.
23. Perretti M., Flower R.J. Annexin 1 and the biology of the neutrophil. J Leukoc Biol 2004, 76:25-29.
24. Godson C., Mitchell S., Harvey K., Petasis N.A., Hogg N., Brady H.R. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte derived macrophages. J Immunol 2000, 164:1663-1667.
25. Serhan C.N., Hamberg M., Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci U S A 1984, 81:5335-5339.
26. Tsai W.H., Shih C.H., Chien H.Y., Lai S.L., Li I.T., Hsu S.C., et al. Annexin A1 mediates the anti-inflammatory effects during the granulocytic differentiation process in all-trans retinoic acid-treated acute promyelocytic leukemic cells. J Cell Physiol 2012, 227:3661-3669.
27. Tsai W.H., Shih C.H., Wu H.Y., Chien H.Y., Chiang Y.C., Lai S.L., et al. Role of lipoxin A4 in the cell-to-cell interaction between all-trans retinoic acid-treated acute promyelocytic leukemic cells and alveolar macrophages. JCell Physiol 2012, 227:1123-1129.
28. Tsai W.H., Lai S.L., Li I.T., Chien H.Y., Shih C.H., Kou Y.R., et al. Annexin A1 mediates the anti-adhesive effects of dexamethasone during the cell-cell interaction between the all-trans retinoic acid-treated acute promyelocytic leukemic cells and endothelial cells. J Cell Biochem 2012, 227:3661-3669.
29. Bone R.C., Balk R.A., Cerra F.B. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655.
30. Goulding N.J., Godolphin J.L., Sharland P.R., Peers S.H., Sampson M., Maddison P.J., et al. Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet 1990, 335:1416-1418.
31. Schramm G.E., Kashyap R., Mullon J.J., Gajic O., Afessa B. Septic shock: a multidisciplinary response team and weekly feedback to clinicians improve the process of care and mortality. Crit Care Med 2012, 39:252.
32. Muenzer J.T., Davis C.G., Chang K., Muenzer J.T., Christopher G.D., Chang K., et al. Characterization and modulation of the immunosuppressive phase of sepsis. Infect Immun 2010, 78:1582.
33. Adib-Conquy M., Cavaillon J.M. Compensatory anti-inflammatory response syndrome. Thromb Haemost 2009, 101:36-47.
34. Kosicka A., Cunliffe A.D., Mackenzie R., Gulrez Zariwala M., Perretti M., Flower R.J., et al. Attenuation of plasma annexin A1 in human obesity. FASEB J 2013, 27:368-378. 10.1096/fj.12-213728.
35. Francis J.W., Balazovich K.J., Smolen J.E., Margolis D.I., Boxer L.A. Human neutrophil annexin I promotes granule aggregation and modulates Ca2-dependent membrane fusion. J Clin Invest 1992, 90:537-544.
36. Hannon R., Croxtall J.D., Getting S.J., Roviezzo F., Yona S., Paul-Clark M.J., et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1/mouse. FASEB J 2003, 27:253-255.
37. Hamano K., Gohra H., Noda H., Katoh T., Fujimura Y., Zampo N., et al. Increased serum interleukin-8: correlation with poor prognosis in patientswith postoperative multiple organ failure. World J Surg 1998, 22:1077-1081.
38. Rivers E.P., Kruse J.A., Jacobsen G., Shah K., Loomba M., Otero R., et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007, 35:2016-2024.
39. Huang S.Y., Tang R.B., Chen S.J., Chung R.L. Serum interleukin-6 level as a diagnostic test in children with sepsis. JCMA 2003, 66:523-527.
40. Schutyser E., Struyf S., Van Damme J. The CC chemokine CCL20 and it receptor CCR6. Cytokine Growth Factor Rev 2003, 14:409-426.
41. Blackwell T.S., Christman J.W. Sepsis and cytokines: a current status. Br J Anaesth 1996, 77:110-117.
42. Shapiro N.I., Trzeciak S., Hollander J.E., Birkhahn R., Otero R., Osborn T.M., et al. The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med 2010, 56:52-59.